비인강암에서 c-kit 단백의 발현 및 유전자 변이의 임상적 의미

키워드

참고문헌 (19)

1. "Re-trospective analysis of 5037 patients with nasopharyngeal cancer treated during 1976-1985 Overal survival and paterns of failure The signi-ficance of neck node involvement in relation to the patern of distant failure Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer Expresion of c-kit and kit ligand proteins in normal human tisue Classes of c-KIT activating mu-tations Proposed mechanisms of action and implications for disease classification and therapy Identification and treatment of chemoresistant inoper-able or metastatic GIST Experience with the selective tyrosine kinase inhibitor imatinib mesylate Expre-sion of HER2 and c-KIT in nasopharyngeal carcinoma Implication for a new therapeutic approach A new cel surface receptor ty-rosine kinase for an unidentified igand", pp.261 108 1310 1417 571 385 1035 3341~70 13 7 25 6 5 9 40 51, Mosby Year Book
2. "Transforming and diferentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine inter-leukin-3-dependent mast cell line"
3. "Otolaryngology-Head and Neck surgery 3rd ed", pp.109~ (1998), St.Louis: Mosby Year Book
4. "Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase II randomized intergroup study 0099", 16(4), pp.1310~1317 (1998)
5. "Paraffin section detection of the c-kit gene product Value in the diagnosis of mast cel disorders", pp.498~504
6. "Classes of c-KIT activating mu-tations: Proposed mechanisms of action and implications for disease classification and therapy", 25(7), pp.570~576 (2001)
7. "Identification and treatment of chemoresistant inoper-able or metastatic GIST: Experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571)", 385, pp.S52~S59 (2002)
8. "Expre-sion of HER2 and c-KIT in nasopharyngeal carcinoma: Implication for a new therapeutic approach", 16(10), pp.1035~1040 (2003)
9. "KIT activation is a ubiquitous feature of gastrointestinal stromal tumors", pp.8118~21
10. "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosinekinase in chronic myeloid leukemia", pp.1031~7
11. "Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-asociation not at the ligand-induced dimerization site", 93(4), pp.1319~1329 (1999)
12. "TCR-independent T cel development mediated by gain-of-oncogene function or los-of-tumor-suppressor gene function", 12(5), pp.487~502 (2000)
13. "Paraffin section detection of the c-kit gene product (CD17 ) in human tisue: Value in the diagnosis of mast cel disorders"
14. "C-kit expression in pediatric solid tumors", 26(4), pp.486~492 (2002)
15. "Expression of KIT (CD17 ) in angiomyolipoma", 26(4), pp.493~497 (2002)
16. "KIT protein expresion and analysis of c-kit gene mutation in adenoid cystic car-cinoma", 12(10), pp.956~960 (1999)
17. "KIT activation is a ubiquitous feature of gastrointestinal stromal tumors", 61(22), pp.8118~8121 (2001)
18. "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia", 344(14), pp.031~1037 (2001)
19. "Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor", 344(14), pp.1052~1056 (2001)

관련 논문AI추천